On June 29, 2015, a new case of Ebola virus disease was identified in Liberia 50 days after interruption of active transmission was achieved on May 9. Since then, a cluster of cases has been identified, all of them from Nedowein in Margibi county. Currently, five people have been confirmed with Ebola virus disease by laboratory testing.
As part of the investigation into the source of this new cluster of infections, samples taken from the first person found to have Ebola were sent to the Liberian National Reference Laboratory for genetic sequencing. Tests on these samples have shown that the virus is genetically similar to viruses that infected many people in Margibi County more than six months ago, in late 2014.
This information provides important insights into the probable origin of the virus responsible for this new flare-up in Liberia. Because the virus appears to be related to the one previously circulating in Liberia, it is unlikely that this recurrence has been caused by virus imported from infected areas of Guinea or Sierra Leone. It also makes it unlikely that this has been caused by a new emergence from a natural reservoir, such as a bat or other animal.
Genetic sequencing on samples from the four other cases in this new outbreak is underway.
Presently, 149 people have been identified as contacts and are being monitored closely. Four of these people have tested positive and are being treated for Ebola virus disease in Ebola treatment centres. As with all cases, the number of contacts has been fluctuating. Some are true contacts, while others are not. When a suspected case is confirmed as negative, all contacts associated with that case are de-listed, which is why the number of contacts has declined this week.
Detailed clinical, epidemiological and laboratory investigations are on-going to identify the initial source of infection. This includes the genetic sequencing that has suggested this virus is linked to virus circulating in earlier chains of transmission in Liberia.
At the time of the diagnosis of the first case of the new cluster, Liberia was mid-way through a 90-day period of heightened surveillance and vigilance, following the completion of 42 days since the burial of the last person infected with Ebola virus disease and the declaration of the interruption of transmission in Liberia. During this period, anyone meeting the clinical criteria for Ebola virus disease has been tested and post-mortem tests for Ebola virus are regularly conducted. The new case of Ebola was detected as a result of the heightened surveillance measures being implemented during this period.
Liberia has undertaken the relevant planning to prepare for and respond to the recurrence of Ebola. The Incident Management System immediately activated a team to carry out a detailed investigation and began tracing people who had been in contact with the young man while he was symptomatic.
The UN system and nongovernmental organizations (NGOs) are supporting the government with staff already in Liberia. The World Health Organization (WHO) has sent additional experts in epidemiology and social mobilization to ensure that the processes needed to stop transmission are in place and that the community is fully involved in identifying contacts. WHO has staff present in all 15 counties of Liberia and is playing a central role in supporting the government’s efforts to strengthen surveillance across the country.
Other UN agencies and partners are assisting households being kept in quarantine. The World Food Program is providing food, UNDP is providing solar lamps and radios, and UNICEF is supplying mattresses and tents to provide families with more space.
The identification of Ebola virus disease and quick activation of a comprehensive, multi-sectoral, inter-agency response shows that capacity exists to quickly identify, track and monitor contacts – one of the core elements of the strategy for stopping further spread of Ebola disease.
The government is keeping the people of Liberia informed of developments and is reinforcing messages on key steps they should take to protect themselves and their communities. WHO and partners are fully committed to assisting the government and communities to end this recurrence of Ebola as rapidly as possible.
Source: WHO
Infection Intel: Revolutionizing Infection Monitoring for Chemotherapy Patients With iTempShield
November 29th 2023Explore how AION Biosystems' iTempShield, a skin-wearable device and software system, could transform infection monitoring for chemotherapy patients, enhancing early detection, and reducing hospitalizations.
TASCS's Annual Infection Prevention Seminar: Keeping Texas Ambulatory Surgery Centers Informed
November 27th 2023The Texas Ambulatory Surgery Center Society (TASCS) hosts an annual infection prevention seminar to educate and support Texas ASCs. Learn about its significance and insights from experts.